AGREEMENT FOR TERMINATION OF LEASEAgreement for Termination of Lease • March 14th, 2017 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations
This Agreement for Termination of Lease and Voluntary Surrender of Premises (this “Agreement”) is made and entered into as of October 31, 2016, by and between ARE-770/784/790 MEMORIAL DRIVE, LLC, a Delaware limited liability company (“Landlord”), and INFINITY PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”), with reference to the following:
AGREEMENT FOR TERMINATION OF LEASEAgreement for Termination of Lease • May 11th, 2022 • Monte Rosa Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
AGREEMENT FOR TERMINATION OF LEASEAgreement for Termination of Lease • December 14th, 2022 • Rubius Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Agreement for Termination of Lease (this “Agreement”) is made and entered into as of December 12, 2022 (the “Effective Date”), by and between ARE-MA REGION NO. 58, LLC, a Delaware limited liability company (“Landlord”), and RUBIUS THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
EXHIBIT 10.2 AGREEMENT FOR TERMINATION OF LEASE THIS AGREEMENT FOR TERMINATION OF LEASE (the "Agreement") is made as of August 12, 1999, by and between THE PRUDENTIAL INSURANCE COMPANY OF AMERICA, a New Jersey corporation ("Landlord"), and PERITUS...Agreement for Termination of Lease • November 12th, 1999 • Peritus Software Services Inc • Services-computer programming services
AGREEMENT FOR TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISESAgreement for Termination of Lease • May 4th, 2023 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Agreement for Termination of Lease and Voluntary Surrender of Premises (this “Agreement”) is made and entered into as of May 2, 2023 (the “Effective Date”), by and between ARE-770/784/790 MEMORIAL DRIVE, LLC, a Delaware limited liability company (“Landlord”), and JOUNCE THERAPEUTICS, INC., a Delaware corporation (“Tenant”), with reference to the following:
AGREEMENT FOR TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISESAgreement for Termination of Lease • March 15th, 2024 • Contineum Therapeutics, Inc. • Pharmaceutical preparations
This Agreement for Termination of Lease and Voluntary Surrender of Premises (this “Agreement”) is made and entered into as of October 25 , 2023, by and between ARE-SD REGION NO. 44, LLC, a Delaware limited liability company (“Landlord”), and PIPELINE THERAPEUTICS, INC., a Delaware corporation (“Tenant”), with reference to the following:
AGREEMENT FOR TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISESAgreement for Termination of Lease • November 9th, 2006 • Gene Logic Inc • In vitro & in vivo diagnostic substances
This Agreement for Termination of Lease and Voluntary Surrender of Premises (this ”Agreement”) is made and entered into as of the 28th day of September, 2006, by and between ARE-MARYLAND NO. 23, LLC, a Delaware limited liability company (“Landlord”), and GENE LOGIC, INC., a Delaware corporation (“Tenant”) with reference to the following:
AGREEMENT FOR TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISESAgreement for Termination of Lease • March 15th, 2022 • Metacrine, Inc. • Pharmaceutical preparations
This Agreement for Termination of Lease and Voluntary Surrender of Premises (this “Agreement”) is made and entered into as of March 11, 2022, by and between ARE-SD REGION NO. 30, LLC, a Delaware limited liability company (“Landlord”), and METACRINE, INC., a Delaware corporation (“Tenant”), with reference to the following:
AGREEMENT FOR TERMINATION OF LEASEAgreement for Termination of Lease • November 14th, 2016 • Eleven Biotherapeutics, Inc. • Pharmaceutical preparations
This Agreement for Termination of Lease and Voluntary Surrender of Premises (this “Agreement”) is made and entered into as of October 14, 2016, by and between ARE-MA REGION NO. 38, LLC, a Delaware limited liability company (“Landlord”), and ELEVEN BIOTHERAPEUTICS, INC., a Delaware corporation (“Tenant”), with reference to the following:
AGREEMENT FOR TERMINATION OF LEASEAgreement for Termination of Lease • November 14th, 2023 • Singular Genomics Systems, Inc. • Laboratory analytical instruments
This Agreement for Termination of Lease (this “Agreement”) is made and entered into as of July 19, 2023, by and between ARE-10933 NORTH TORREY PINES, LLC, a Delaware limited liability company (“Landlord”), and SINGULAR GENOMICS SYSTEMS, INC., a Delaware corporation (“Tenant”), with reference to the following:
AGREEMENT FOR TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISESAgreement for Termination of Lease • February 22nd, 2013 • Telik Inc • Pharmaceutical preparations
This Agreement for Termination of Lease and Voluntary Surrender of Premises (this “Agreement”) is made and entered into as of February 19, 2013, by and between ARE-SAN FRANCISCO NO. 24, LLC, a Delaware limited liability company (“Landlord”), and TELIK, INC., a Delaware corporation (“Tenant”), with reference to the following:
AGREEMENT FOR TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISESAgreement for Termination of Lease • July 28th, 2020 • Zentalis Pharmaceuticals, Inc. • Pharmaceutical preparations
This Agreement for Termination of Lease and Voluntary Surrender of Premises (this “Agreement”) is made and entered into as of July 14, 2020, by and between ARE-SD REGION NO. 44, LLC, a Delaware limited liability company (“Landlord”), and ZENO MANAGEMENT, INC., a Delaware corporation (“Tenant”), doing business as Zentalis Pharmaceuticals, with reference to the following:
AGREEMENT FOR TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISESAgreement for Termination of Lease • May 15th, 2014 • Signal Genetics LLC • Services-medical laboratories
THIS AGREEMENT FOR TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISES (this “Agreement”) is made and entered into as of the 14th day of March, 2014, by and between ARE-ACQUISITIONS, LLC, a Delaware limited liability company (“Landlord”), and SIGNAL GENETICS LLC, a Delaware limited liability company (“Tenant”), with reference to the following:
AGREEMENT FOR TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISESAgreement for Termination of Lease • August 7th, 2009 • Metabasis Therapeutics Inc • Pharmaceutical preparations • California
This Agreement for Termination of Lease and Voluntary Surrender of Premises (this “Agreement”) is made as of July 21, 2009, by and between ARE-SD Region No. 24, LLC, a Delaware limited liability company (“Owner”) and Metabasis Therapeutics, Inc., a Delaware corporation (“Metabasis”) with reference to the following:
AGREEMENT FOR TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISESAgreement for Termination of Lease • December 16th, 2020 • Frequency Therapeutics, Inc. • Pharmaceutical preparations
This Agreement for Termination of Lease and Voluntary Surrender of Premises (this “Agreement”) is made and entered into as of December 11, 2020 (“Effective Date”), by and between ARE-MA REGION NO. 20, LLC, a Delaware limited liability company (“Landlord”), and FREQUENCY THERAPEUTICS, INC., a Delaware corporation (“Tenant”), with reference to the following:
